BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38563861)

  • 1. The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
    Papadakos KS; Gorji-Bahri G; Gialeli C; Hedner C; Hagerling C; Svensson MC; Jeremiasen M; Borg D; Fristedt R; Jirström K; Blom AM
    Cancer Immunol Immunother; 2024 Apr; 73(5):93. PubMed ID: 38563861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion.
    Papadakos KS; Lundgren S; Gialeli C; Micke P; Mezheyeuski A; Elebro J; Jirström K; Blom AM
    Oncoimmunology; 2022; 11(1):2111906. PubMed ID: 35990519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression.
    Blom AM; Gialeli C; Hagerling C; Berntsson J; Jirström K; Papadakos KS
    Front Immunol; 2023; 14():1167659. PubMed ID: 37207219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
    Englund E; Bartoschek M; Reitsma B; Jacobsson L; Escudero-Esparza A; Orimo A; Leandersson K; Hagerling C; Aspberg A; Storm P; Okroj M; Mulder H; Jirström K; Pietras K; Blom AM
    Oncogene; 2016 Oct; 35(43):5585-5596. PubMed ID: 27065333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
    Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Levels of Expression of Cartilage Oligomeric Matrix Protein in Lymph Node Metastases in Breast Cancer Are Associated with Reduced Survival.
    Papadakos KS; Hagerling C; Rydén L; Larsson AM; Blom AM
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34884987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
    Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
    Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis.
    Magdaleno F; Arriazu E; Ruiz de Galarreta M; Chen Y; Ge X; Conde de la Rosa L; Nieto N
    J Hepatol; 2016 Nov; 65(5):963-971. PubMed ID: 27318326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
    Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival.
    Wusterbarth E; Chen Y; Jecius H; Krall E; Runyan RB; Pandey R; Nfonsam V
    J Surg Res; 2022 Feb; 270():169-177. PubMed ID: 34687957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage oligomeric matrix protein (COMP) promotes cell proliferation in early-onset colon cancer tumorigenesis.
    Nfonsam VN; Jecius HC; Janda J; Omesiete PN; Elquza E; Scott AJ; Nfonsam LE; Jandova J
    Surg Endosc; 2020 Sep; 34(9):3992-3998. PubMed ID: 31617091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies.
    Agarwal P; Schulz JN; Blumbach K; Andreasson K; Heinegård D; Paulsson M; Mauch C; Eming SA; Eckes B; Krieg T
    Matrix Biol; 2013 Aug; 32(6):325-31. PubMed ID: 23507196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival.
    Christina Svensson M; Lindén A; Nygaard J; Borg D; Hedner C; Nodin B; Leandersson K; Jirström K
    Oncoimmunology; 2021 May; 10(1):1921443. PubMed ID: 34104541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients.
    Nfonsam VN; Nfonsam LE; Chen D; Omesiete PN; Cruz A; Runyan RB; Jandova J
    J Surg Res; 2019 Jan; 233():297-303. PubMed ID: 30502262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma.
    Quaas A; Pamuk A; Klein S; Quantius J; Rehkaemper J; Barutcu AG; Rueschoff J; Zander T; Gebauer F; Hillmer A; Buettner R; Schroeder W; Bruns CJ; Löser H; Schoemig-Markiefka B; Alakus H
    Gastric Cancer; 2021 Nov; 24(6):1213-1226. PubMed ID: 34009535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.
    Borg D; Hedner C; Nodin B; Larsson A; Johnsson A; Eberhard J; Jirström K
    BMC Clin Pathol; 2016; 16():13. PubMed ID: 27478410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
    Borg D; Larsson AH; Hedner C; Nodin B; Johnsson A; Jirström K
    J Transl Med; 2018 Oct; 16(1):290. PubMed ID: 30355278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMP promotes pancreatic fibrosis by activating pancreatic stellate cells through CD36-ERK/AKT signaling pathways.
    Wang Y; Li HT; Liu G; Jiang CS; Ni YH; Zeng JH; Lin X; Wang QY; Li DZ; Wang W; Zeng XP
    Cell Signal; 2024 Jun; 118():111135. PubMed ID: 38479555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage oligomeric matrix protein (COMP)-mediated cell differentiation to proteolysis mechanism networks from human normal adjacent tissues to lung adenocarcinoma.
    Wang L; Huang J; Jiang M; Diao H; Zhou H; Li X; Chen Q; Jiang Z; Feng H; Wolfl S
    Anal Cell Pathol (Amst); 2013; 36(3-4):93-105. PubMed ID: 24064399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.